The Medicines and Healthcare products Regulatory Agency (MHRA) has changed the licence for valproate medicines (Epilim, Depakote and generic brands) so it must no longer be prescribed to women or girls of childbearing potential unless they are on the Pregnancy Prevention Programme (PPP). This is because valproate is associated with a significant risk of birth...
Date issued: 24th April 2018 A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 11, Issue 9, April 2018) has been published and includes articles on: valproate medicines (Epilim▼, Depakote▼): contraindicated in women and girls of childbearing potential unless conditions of Pregnancy Prevention Programme are met; obeticholic acid (Ocaliva▼): risk of...
Community pharmacy contractors and LPCs may be aware that the All-Party Pharmacy Group (APPG) has today made a statement on the upcoming negotiations on community pharmacy funding. This follows communication between Sir Kevin Barron MP, who is Chair of the All-Party Pharmacy Group (APPG), and the Pharmacy Minister Steve Brine. The Minister said he had...
With investment from the Pharmacy Integration Fund, the Centre for Pharmacy Postgraduate Education (CPPE) collaborated with the NHS Leadership Academy in 2017 to offer the Mary Seacole programme to pharmacists and pharmacy technicians working in community pharmacy. There are now further opportunities to access the Mary Seacole programme available for booking in 2018 across England....
2018 marks 70 years since the NHS came into being and events are being planned throughout the year to celebrate this milestone. As part of the ‘NHS70’ celebrations, NHS England is running a 10-day event to highlight the role of primary care in the NHS, and community pharmacy teams are encouraged to join in. Between...
Recent Comments